← Eichor
Condition: Post Liver Transplant Infection Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Post Liver Transplant Infection

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Fecal Microbiota Transplantation for the Prevention of Infectious Complications After Liver Transplantation
NA · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06782880A Study to Investigate the Safety and Efficacy of Undiluted Intravenous Infusion of I.V.-Hepabig Inj.
Phase 3 · 8 location(s) · GC Biopharma Corp · NCT05686759Effect of Preoperative Vitamin D Supplementation in Liver Transplant Recipients With Vitamin D Deficiency on Post Transp
NA · 1 location(s) · Institute of Liver and Biliary Sciences, India · NCT06736093Cell Free DNA Profiling As a Tool to Monitor Clinically-Relevant Events in Allogeneic Hematopoietic Stem Cell Transplant
Phase N/A · 2 location(s) · University of Turin, Italy · NCT06715046A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
Phase 2 · 26 location(s) · Deciphera Pharmaceuticals, LLC · NCT06619561A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative
Phase 3 · 71 location(s) · Pierre Fabre Medicament · NCT03394365Quantiferon CMV to Identify Treatment Need for Asymptomatic CMV Infection After Solid Organ Transplant (QUANTIFOT)
NA · 1 location(s) · University Hospital, Grenoble · NCT06341543
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.